Trials / Terminated
TerminatedNCT01820520
Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Asociación para Evitar la Ceguera en México · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Study designed to evaluate the safety and efficacy of double staining with brilliant blue G 0.025% as an adjuvant to macular surgery. Patients undergoing surgery for macular hole or epiretinal membrane will be included. Safety will be evaluated by optic coherence tomography, pattern reversal electroretinogram and multifocal electroretinogram.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | brilliant blue G | Double staining with brilliant blue G 0.025% for macular surgery |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2013-03-28
- Last updated
- 2024-05-30
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01820520. Inclusion in this directory is not an endorsement.